Graphite Bio

+$0.29 (+2.35%) Today
$0.00 (0.00%) As of 8:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Graphite Bio and other ETFs, options, and stocks.

About GRPH

Graphite Bio, Inc. operates as a clinical-stage gene editing company. It focuses on therapies that harness targeted gene integration to treat or cure serious diseases.

CEO
Joshua Lehrer-Graiwer
Employees
—
Headquarters
South San Francisco, California
Founded
2017

GRPH Key Statistics

Market Cap
734.12M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
201.13K
High Today
$12.78
Low Today
$12.10
Open Price
$12.49
Volume
130.15K
52 Week High
$34.00
52 Week Low
$11.72

GRPH Earnings

-$3.45
-$2.30
-$1.15
$0.00
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure